Xu, S., Wang, W., Xu, C., Li, X., Ye, J., Zhu, Y., & Ge, T. (2019). ROS1-ADGRG6: A case report of a novel ROS1 oncogenic fusion variant in lung adenocarcinoma and the response to crizotinib. BMC Cancer.
Chicago-tyylinen lähdeviittausXu, Shuguang, Wenxian Wang, Chunwei Xu, Xingliang Li, Junhui Ye, Youcai Zhu, ja Ting Ge. "ROS1-ADGRG6: A Case Report of a Novel ROS1 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Crizotinib." BMC Cancer 2019.
MLA-viiteXu, Shuguang, et al. "ROS1-ADGRG6: A Case Report of a Novel ROS1 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Crizotinib." BMC Cancer 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.